- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-tetramer
- Ligands
- 8 x ERG: ERGOSTEROL(Non-covalent)
- 8 x CPL: 1-PALMITOYL-2-LINOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)
CPL.3: 11 residues within 4Å:- Chain A: F.343, C.346, C.347, L.373, Y.377, L.386, E.389, T.392, M.440, R.443, L.444
8 PLIP interactions:8 interactions with chain A- Hydrophobic interactions: A:F.343, A:Y.377, A:Y.377, A:E.389, A:T.392, A:M.440, A:R.443, A:L.444
CPL.5: 18 residues within 4Å:- Chain A: I.337, I.341, T.344, T.345, I.348, Y.349
- Chain D: C.494, W.495, A.498, V.499, L.502, H.509, D.525, Y.526, P.527, L.530
- Ligands: ECN.4, ERG.18
13 PLIP interactions:8 interactions with chain D, 5 interactions with chain A- Hydrophobic interactions: D:W.495, D:A.498, D:V.499, D:L.502, D:Y.526, D:P.527, D:L.530, A:I.337, A:I.337, A:I.341, A:I.341, A:T.344
- Hydrogen bonds: D:Y.526
CPL.6: 18 residues within 4Å:- Chain A: C.494, W.495, A.498, V.499, L.502, H.509, D.525, Y.526, P.527, L.530
- Chain B: I.337, I.341, T.344, T.345, I.348, Y.349
- Ligands: ERG.2, ECN.10
13 PLIP interactions:8 interactions with chain A, 5 interactions with chain B- Hydrophobic interactions: A:W.495, A:A.498, A:V.499, A:L.502, A:Y.526, A:P.527, A:L.530, B:I.337, B:I.337, B:I.341, B:I.341, B:T.344
- Hydrogen bonds: A:Y.526
CPL.9: 11 residues within 4Å:- Chain B: F.343, C.346, C.347, L.373, Y.377, L.386, E.389, T.392, M.440, R.443, L.444
8 PLIP interactions:8 interactions with chain B- Hydrophobic interactions: B:F.343, B:Y.377, B:Y.377, B:E.389, B:T.392, B:M.440, B:R.443, B:L.444
CPL.11: 18 residues within 4Å:- Chain B: C.494, W.495, A.498, V.499, L.502, H.509, D.525, Y.526, P.527, L.530
- Chain C: I.337, I.341, T.344, T.345, I.348, Y.349
- Ligands: ERG.8, ECN.15
13 PLIP interactions:8 interactions with chain B, 5 interactions with chain C- Hydrophobic interactions: B:W.495, B:A.498, B:V.499, B:L.502, B:Y.526, B:P.527, B:L.530, C:I.337, C:I.337, C:I.341, C:I.341, C:T.344
- Hydrogen bonds: B:Y.526
CPL.14: 11 residues within 4Å:- Chain C: F.343, C.346, C.347, L.373, Y.377, L.386, E.389, T.392, M.440, R.443, L.444
9 PLIP interactions:9 interactions with chain C- Hydrophobic interactions: C:F.343, C:Y.377, C:Y.377, C:L.386, C:E.389, C:T.392, C:M.440, C:R.443, C:L.444
CPL.16: 18 residues within 4Å:- Chain C: C.494, W.495, A.498, V.499, L.502, H.509, D.525, Y.526, P.527, L.530
- Chain D: I.337, I.341, T.344, T.345, I.348, Y.349
- Ligands: ERG.13, ECN.20
13 PLIP interactions:8 interactions with chain C, 5 interactions with chain D- Hydrophobic interactions: C:W.495, C:A.498, C:V.499, C:L.502, C:Y.526, C:P.527, C:L.530, D:I.337, D:I.337, D:I.341, D:I.341, D:T.344
- Hydrogen bonds: C:Y.526
CPL.19: 11 residues within 4Å:- Chain D: F.343, C.346, C.347, L.373, Y.377, L.386, E.389, T.392, M.440, R.443, L.444
8 PLIP interactions:8 interactions with chain D- Hydrophobic interactions: D:F.343, D:Y.377, D:Y.377, D:E.389, D:T.392, D:M.440, D:R.443, D:L.444
- 4 x ECN: 1-[(2S)-2-[(4-CHLOROBENZYL)OXY]-2-(2,4-DICHLOROPHENYL)ETHYL]-1H-IMIDAZOLE(Non-covalent)
ECN.4: 12 residues within 4Å:- Chain A: S.334, I.337, V.465, M.466, F.468, A.469, F.472, L.475
- Chain D: W.495, L.496, V.499
- Ligands: CPL.5
5 PLIP interactions:2 interactions with chain D, 3 interactions with chain A- Hydrophobic interactions: D:W.495, D:W.495, A:I.337, A:F.468, A:L.475
ECN.10: 12 residues within 4Å:- Chain A: W.495, L.496, V.499
- Chain B: S.334, I.337, V.465, M.466, F.468, A.469, F.472, L.475
- Ligands: CPL.6
5 PLIP interactions:2 interactions with chain A, 3 interactions with chain B- Hydrophobic interactions: A:W.495, A:W.495, B:I.337, B:F.468, B:L.475
ECN.15: 12 residues within 4Å:- Chain B: W.495, L.496, V.499
- Chain C: S.334, I.337, V.465, M.466, F.468, A.469, F.472, L.475
- Ligands: CPL.11
5 PLIP interactions:2 interactions with chain B, 3 interactions with chain C- Hydrophobic interactions: B:W.495, B:W.495, C:I.337, C:F.468, C:L.475
ECN.20: 12 residues within 4Å:- Chain C: W.495, L.496, V.499
- Chain D: S.334, I.337, V.465, M.466, F.468, A.469, F.472, L.475
- Ligands: CPL.16
5 PLIP interactions:3 interactions with chain D, 2 interactions with chain C- Hydrophobic interactions: D:I.337, D:F.468, D:L.475, C:W.495, C:W.495
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- De Jesus-Perez, J.J. et al., Structural mechanism of TRPV5 inhibition by econazole. Structure (2024)
- Release Date
- 2024-01-10
- Peptides
- Transient receptor potential cation channel subfamily V member 5: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-tetramer
- Ligands
- 8 x ERG: ERGOSTEROL(Non-covalent)
- 8 x CPL: 1-PALMITOYL-2-LINOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)
- 4 x ECN: 1-[(2S)-2-[(4-CHLOROBENZYL)OXY]-2-(2,4-DICHLOROPHENYL)ETHYL]-1H-IMIDAZOLE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- De Jesus-Perez, J.J. et al., Structural mechanism of TRPV5 inhibition by econazole. Structure (2024)
- Release Date
- 2024-01-10
- Peptides
- Transient receptor potential cation channel subfamily V member 5: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D - Membrane
-
We predict this structure to be a membrane protein.